Nuevolution AB (publ) announces timing for the second quarter release and webcast

Stockholm, 2 February 2017 – Nuevolution AB (publ) (NUE.ST) announces today that it will report its second quarter 2016/17 financial results on Wednesday 8 February at 8:30 CET.

On Wednesday 8 February at 14:00 CET, the company’s CEO and CFO will host a conference call and webcast presentation of the results and provide an update on partnering activities and pipeline programs. Access to the event can be obtained as follows:

LIVE access on Wednesday 8 February at 14:00 CET

Telephone numbers:
SE: +46 85 664 2666
DK: +45 3544 5575
UK: +44 20 3008 9808
US: +1 855 831 5946

Webcast available at in the Investors section and at

REPLAY access

Webcast replay will be available on Nuevolution’s website at in the Investors section and at

For more information, please contact:

Alex Haahr Gouliaev, CEO
Phone: +45 3913 0902

Henrik Damkjær Simonsen, CFO
Phone: +45 3913 0947

Information about Nuevolution AB (publ)

Nuevolution AB (publ) is a leading small molecule drug discovery biotech company founded in 2001, and headquartered in Copenhagen, Denmark. Nuevolution partners its discovery platform and programs with pharmaceutical and biotechnology companies to seek future benefit of patients in need of novel medical treatment option. Nuevolution’s internal programs are focused on therapeutically important targets within inflammation, oncology and immuno-oncology.

Nuevolution AB (publ) is required to disclose the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act. The information was sent for publication on Thursday 2 February 2017 at 11:00 CET.

Nuevolution AB (publ) is listed at Nasdaq First North in Stockholm, Sweden (ticker: NUE). Redeye AB acts as Certified Advisor to Nuevolution AB (publ). More information about Nuevolution can be found on: